Aliases & Classifications for Amyloid Tumor

MalaCards integrated aliases for Amyloid Tumor:

Name: Amyloid Tumor 12 14 69
Amyloid Neoplasm 12

Classifications:



External Ids:

Disease Ontology 12 DOID:6755
SNOMED-CT 64 37279009
UMLS 69 C0333572

Summaries for Amyloid Tumor

MalaCards based summary : Amyloid Tumor, also known as amyloid neoplasm, is related to denture stomatitis and tibial nerve palsy. An important gene associated with Amyloid Tumor is B2M (Beta-2-Microglobulin), and among its related pathways/superpathways are Neuroscience and FOXA2 and FOXA3 transcription factor networks. The drugs Valsartan and Angiotensin II have been mentioned in the context of this disorder. Affiliated tissues include breast, bone and bone marrow, and related phenotypes are Negative genetic interaction between PTTG1-/- and PTTG1+/+ and neoplasm

Related Diseases for Amyloid Tumor

Diseases related to Amyloid Tumor via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 105)
id Related Disease Score Top Affiliating Genes
1 denture stomatitis 10.7 B2M TTR
2 tibial nerve palsy 10.7 B2M TTR
3 bacteriuria 10.7 B2M TTR
4 macular dystrophy, patterned, 1 10.7 B2M TTR
5 hereditary congenital facial paresis 10.7 B2M TTR
6 amyloidosis nodular localized cutaneous 10.7 B2M TTR
7 pyosalpinx 10.7 B2M TTR
8 peripheral nerve schwannoma 10.7 B2M MYOM2
9 alopecia-mental retardation syndrome 3 10.7 B2M TTR
10 theileriasis 10.6 B2M MYOM2
11 benign paroxysmal positional nystagmus 10.6 NF2 TUBB3
12 cardiovascular cancer 10.6 NF2 TUBB3
13 46 xy gonadal dysgenesis 10.5 B2M CD79A
14 non-congenital cyst of kidney 10.5 B2M CD79A
15 eustachian tube disease 10.5 B2M PKDREJ
16 hypervitaminosis a 10.5 CD79A TTR
17 immune-complex glomerulonephritis 10.5 B2M CD79A
18 necrobiosis lipoidica 10.5 CD79A TTR
19 male genital organ stricture 10.5 CD79A TTR
20 inclusion conjunctivitis 10.5 B2M CD79A
21 solitary bone cyst 10.4 B2M CD79A
22 anal canal squamous cell carcinoma 10.4 B2M CALCA
23 nasopharyngeal disease 10.4 CD79A MYOM2
24 hemopericardium 10.4 CALCA TTR
25 generalized atherosclerosis 10.4 CD79A MYOM2
26 juvenile dermatitis herpetiformis 10.4 CALCA MYOM2
27 neurofibromatosis-noonan syndrome 10.4 NF1 NF2
28 osteogenesis imperfecta, type iii 10.3 PKDREJ SPARC
29 indolent myeloma 10.3 CD79A MYOM2
30 spastic entropion 10.3 CD79A TTR
31 arteriosclerosis 10.3 CD79A MYOM2
32 pancreatic acinar cell adenocarcinoma 10.3 MYOM2 TTR TUBB3
33 peripheral vertigo 10.3 NF1 TUBB3
34 pediatric fibrosarcoma 10.3 NF1 NF2
35 demyelinating disease 10.3 NF1 NF2
36 benign pleural mesothelioma 10.3 NF1 NF2
37 ovarian disease 10.3 NF1 NF2
38 borna disease 10.3 NF1 NF2
39 tricuspid valve insufficiency 10.3 CALCA PKDREJ
40 polydactyly, postaxial, with progressive myopia 10.3 NF1 TUBB3
41 epilepsy, familial focal, with variable foci 1 10.3 NF1 NF2
42 late yaws 10.2 B2M CD79A
43 foodborne botulism 10.2 CD79A MYOM2
44 c-p angle neurinoma 10.2 NF1 NF2
45 vestibular disease 10.2 NF1 NF2
46 mitochondrial myopathy with lactic acidosis 10.2 NF1 SPARC
47 bladder sarcoma 10.2 CD79A TTR
48 peritoneal benign neoplasm 10.2 NF1 NF2
49 central nervous system origin vertigo 10.2 B2M CD79A
50 membranoproliferative glomerulonephritis 10.2 CD79A MYOM2

Graphical network of the top 20 diseases related to Amyloid Tumor:



Diseases related to Amyloid Tumor

Symptoms & Phenotypes for Amyloid Tumor

GenomeRNAi Phenotypes related to Amyloid Tumor according to GeneCards Suite gene sharing:

26
id Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Negative genetic interaction between PTTG1-/- and PTTG1+/+ GR00255-A-4 8.92 B2M MYOM2 TTR TUBB3

MGI Mouse Phenotypes related to Amyloid Tumor:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 neoplasm MP:0002006 9.02 B2M CD79A NF1 NF2 SPARC

Drugs & Therapeutics for Amyloid Tumor

Drugs for Amyloid Tumor (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 291)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Valsartan Approved, Investigational Phase 4 137862-53-4 60846
2
Angiotensin II Investigational Phase 4 68521-88-0, 4474-91-3, 11128-99-7 172198 65143
3 Antihypertensive Agents Phase 4,Phase 2,Phase 1
4 Anti-Inflammatory Agents Phase 4,Phase 3,Phase 2,Phase 1
5 Hormones Phase 4,Phase 3,Phase 2,Phase 1
6 Angiotensin II Type 1 Receptor Blockers Phase 4
7 Angiotensin Receptor Antagonists Phase 4
8 Angiotensinogen Phase 4
9
Ketamine Approved, Vet_approved Phase 3 6740-88-1 3821
10
Dexamethasone Approved, Investigational, Vet_approved Phase 3,Phase 2,Phase 1 50-02-2 5743
11
Lenograstim Approved Phase 3,Phase 2,Phase 1 135968-09-1
12
Melphalan Approved Phase 3,Phase 2,Phase 1 148-82-3 4053 460612
13
Cyclophosphamide Approved, Investigational Phase 3,Phase 2,Phase 1 50-18-0, 6055-19-2 2907
14
Lenalidomide Approved Phase 3,Phase 1,Phase 2 191732-72-6 216326
15
Flutamide Approved Phase 3,Phase 2 13311-84-7 3397
16
Leuprolide Approved, Investigational Phase 3,Phase 2 53714-56-0 3911 657181
17
Bortezomib Approved, Investigational Phase 3,Phase 2,Phase 1 179324-69-7 387447 93860
18
Mechlorethamine Approved Phase 3,Phase 1,Phase 2 51-75-2 4033
19
Dalteparin Approved Phase 3 9005-49-6
20
Heparin Approved, Investigational Phase 3 9005-49-6 772 46507594
21
Darbepoetin alfa Approved, Investigational Phase 3 11096-26-7, 209810-58-2
22
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
23
Amphotericin B Approved, Investigational Phase 3 1397-89-3 14956 5280965
24
Miconazole Approved, Investigational, Vet_approved Phase 3,Phase 1,Phase 2 22916-47-8 4189
25
Ondansetron Approved Phase 3 99614-02-5 4595
26
Iron Approved Phase 3,Phase 1,Phase 2 7439-89-6 23925
27
Caspofungin Approved Phase 3,Phase 2 179463-17-3, 162808-62-0 468682 2826718
28
Dextromethorphan Approved Phase 3 125-71-3 5360696 5362449
29
Guaifenesin Approved, Vet_approved Phase 3 93-14-1 3516
30
Morphine Approved, Investigational Phase 3 57-27-2 5288826
31
Daratumumab Approved Phase 3,Phase 1 945721-28-8
32 Ixazomib Approved Phase 3,Phase 1,Phase 2 1072833-77-2
33
Bicalutamide Approved Phase 3 90357-06-5 56069 2375
34
Buserelin Approved Phase 3 57982-77-1
35
Goserelin Approved Phase 3 65807-02-5 47725 5311128
36
Celecoxib Approved, Investigational Phase 3 169590-42-5 2662
37
Ginseng Approved, Nutraceutical Phase 3 50647-08-0
38
Glycine Approved, Nutraceutical, Vet_approved Phase 3,Phase 1,Phase 2 56-40-6 750
39
Ergocalciferol Approved, Nutraceutical Phase 3 50-14-6 5280793
40
Vitamin D Approved, Nutraceutical, Vet_approved Phase 3 1406-16-2
41 Pancreatic Polypeptide Investigational Phase 3 59763-91-6
42 Analgesics Phase 3,Phase 1
43 Anesthetics Phase 3
44 Anesthetics, Dissociative Phase 3
45 Anesthetics, General Phase 3
46 Anesthetics, Intravenous Phase 3
47 Central Nervous System Depressants Phase 3,Phase 1,Phase 2
48 Excitatory Amino Acid Antagonists Phase 3
49 Excitatory Amino Acids Phase 3
50 Neurotransmitter Agents Phase 3,Phase 1,Phase 2

Interventional clinical trials:

(show top 50) (show all 172)

id Name Status NCT ID Phase Drugs
1 Anti-Inflammatory Actions of Valsartan in Patients With Type 2 Diabetes Mellitus Completed NCT00982358 Phase 4 Valsartan
2 TARGIT-C(Consolidation) Prospective Phase IV Study of IORT in Patients With Small Breast Cancer Recruiting NCT02290782 Phase 4
3 Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain Unknown status NCT01316744 Phase 3 ketamine hydrochloride
4 Low-Dose Melphalan and Dexamethasone Compared With High-Dose Melphalan Followed By Autologous Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis Completed NCT00477971 Phase 3 dexamethasone;melphalan
5 Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis Completed NCT01078454 Phase 3 melphalan;dexamethasone;bortezomib
6 Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter Completed NCT00006083 Phase 3 Fragmin
7 Melphalan Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma Completed NCT00004165 Phase 3 melphalan
8 Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain Completed NCT00666211 Phase 3
9 St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer Completed NCT00005805 Phase 3
10 Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer Completed NCT00070382 Phase 3 darbepoetin alfa;epoetin alfa
11 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3 Fentanyl sublingual spray;Placebo
12 Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients Completed NCT00003938 Phase 3 liposomal amphotericin B
13 Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment Completed NCT00006348 Phase 3 ondansetron
14 American Ginseng in Treating Patients With Fatigue Caused by Cancer Completed NCT00719563 Phase 3 American ginseng
15 Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer Completed NCT00661999 Phase 3 sodium ferric gluconate complex in sucrose
16 Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment Completed NCT00008359 Phase 3 caspofungin acetate;liposomal amphotericin B
17 Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis Completed NCT00035334 Phase 2, Phase 3 NC-503 (Anti-amyloidotic (AA) Agent)
18 Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial Completed NCT00750009 Phase 3
19 Treatment for Chronic Pain in Patients With Advanced Cancer Completed NCT00003687 Phase 3 dextromethorphan hydrobromide;morphine sulfate
20 A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis Recruiting NCT03201965 Phase 3 Cyclophosphamide;Bortezomib;Dexamethasone, 40 mg;Daratumumab
21 Study of Dexamethasone Plus IXAZOMIB (MLN9708) or Physicians Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis Recruiting NCT01659658 Phase 3 IXAZOMIB;Dexamethasone;Melphalan;Cyclophosphamide;Thalidomide;Lenalidomide
22 Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer Active, not recruiting NCT00567580 Phase 3 bicalutamide;flutamide
23 The VITAL Amyloidosis Study, a Global Phase 3, Efficacy and Safety Study of NEOD001 in Patients With AL Amyloidosis Active, not recruiting NCT02312206 Phase 3 NEOD001
24 Adjuvant Celecoxib in Completely Resected pN1-2 NSCLC Patients Suspended NCT00211952 Phase 3 celecoxib
25 Effect of Vitamin D Supplement on Inflammation Markers in High-Risk Cardiovascular Patients With Chronic Kidney Disease Terminated NCT01012414 Phase 3 paricalcitol;placebo
26 S0115, High-Dose Melphalan and Autologous Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Primary Systemic Amyloidosis Unknown status NCT00064337 Phase 2 cyclophosphamide;dexamethasone;melphalan;thalidomide
27 Intermittent Hormone Therapy in Men With Localized Prostate Cancer After Radiation Therapy or Radical Prostatectomy Unknown status NCT00223665 Phase 2 Flutamide;Leuprolide Acetate
28 Lenalidomide, Dexamethasone and Cyclophosphamide in Amyloidosis (AL) Unknown status NCT00981708 Phase 1, Phase 2 Lenalidomide, Dexamethasone and Cyclophosphamide
29 Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Other B-cell Cancers Unknown status NCT00003163 Phase 2 cyclophosphamide;melphalan
30 Melphalan, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed, Previously Untreated Primary Systemic Amyloidosis Completed NCT00089167 Phase 2 dexamethasone;melphalan;thalidomide
31 Melphalan and Autologous Stem Cell Transplant Followed By Bortezomib and Dexamethasone in Treating Patients With Previously Untreated Systemic Amyloidosis Completed NCT00458822 Phase 2 bortezomib;dexamethasone
32 Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients Who Have Multiple Myeloma or Primary Systemic Amyloidosis Completed NCT00007995 Phase 2 busulfan;cyclophosphamide;melphalan
33 High-Dose Melphalan Plus Peripheral Stem Cell Transplantation in Treating Patients With Primary Systemic Amyloidosis Completed NCT00003353 Phase 2 melphalan
34 4'-Iodo-4'-Deoxydoxorubicin in Treating Patients With Primary Systemic Amyloidosis Completed NCT00003853 Phase 2 4'-iodo-4'-deoxydoxorubicin
35 High-Dose Melphalan Followed by Peripheral Stem Cell Transplant in Treating Patients With Amyloidosis Completed NCT00002810 Phase 2 melphalan
36 Human Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart Dysfunction Completed NCT00547365 Phase 1, Phase 2
37 Study of High-Dose Melphalan and Autologous Stem Cell Transplantation in Patients With Primary Light Chain Amyloidosis Completed NCT00017680 Phase 2 Melphalan
38 Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Primary Systemic Amyloidosis Completed NCT00564889 Phase 2 cyclophosphamide;dexamethasone;lenalidomide
39 S9628 Dexamethasone Plus Interferon Alfa in Treating Patients With Primary Systemic Amyloidosis Completed NCT00002849 Phase 2 dexamethasone
40 Trial of Two Stem Cell Doses To Reduce Transplant Induced Symptom Burden Completed NCT00651937 Phase 2 Melphalan;Granulocyte-colony stimulating factor (G-CSF)
41 Doxorubicin and Cyclophosphamide (AC) Followed by Weekly Docetaxel as Neoadjuvant Treatment of Breast Cancer Patients Completed NCT00129376 Phase 2 docetaxel
42 Therapy With Bevacizumab (BEV), Epirubicin, and Cyclophosphamide Followed by Docetaxel Plus Trastuzumab and BEV Given as Neoadjuvant or Adjuvant Therapy for Women With Locally Advanced HER2 Positive Invasive Breast Cancer Completed NCT00464646 Phase 2 Epirubicin;Cyclophosphamide;Docetaxel;Trastuzumab;Bevacizumab
43 Efficacy of CC-5013 (Revlimid or Lenalidomide) in Patients With Primary Systemic Amyloidosis Completed NCT00166413 Phase 2 CC-5013
44 Bortezomib, Cyclophosphamide, and Dexamethasone in Treating Patients With Primary Systemic Light Chain Amyloidosis Completed NCT01072773 Phase 2 bortezomib;cyclophosphamide;dexamethasone
45 CC-5013 With or Without Dexamethasone in Treating Patients With Primary Systemic Amyloidosis Completed NCT00091260 Phase 2 dexamethasone;lenalidomide
46 Melphalan, Lenalidomide, and Dexamethasone in Treating Patients With Primary Systemic Amyloidosis Completed NCT00679367 Phase 2 dexamethasone;lenalidomide;melphalan
47 Melphalan, Bortezomib, and Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis Completed NCT00790647 Phase 2 bortezomib;melphalan
48 Bexarotene Amyloid Treatment for Alzheimer's Disease Completed NCT01782742 Phase 2 Bexarotene;Placebo
49 High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors Completed NCT00060255 Phase 2 busulfan;carboplatin;carmustine;cyclophosphamide;etoposide;melphalan;thiotepa
50 Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer Completed NCT00245037 Phase 1, Phase 2 busulfan;cyclosporine;fludarabine phosphate;mycophenolate mofetil;Granulocyte colony-stimulating factor (G-CSF);Phenytoin;Methotrexate

Search NIH Clinical Center for Amyloid Tumor

Genetic Tests for Amyloid Tumor

Anatomical Context for Amyloid Tumor

MalaCards organs/tissues related to Amyloid Tumor:

39
Breast, Bone, Bone Marrow, Liver, Brain, Lung, Prostate

Publications for Amyloid Tumor

Articles related to Amyloid Tumor:

(show top 50) (show all 69)
id Title Authors Year
1
Calcified amyloid tumor of neck with exuberant giant cell reaction. ( 25949063 )
2015
2
Incidental Discovery of Multiple Myeloma, Presenting as an Amyloid Tumor with Plasmacytic Elements of the Thoracic Wall. ( 26710503 )
2015
3
Prostate amyloid tumor is a clue leading to the diagnosis of systemic AL amyloidosis. ( 23826754 )
2013
4
Amyloid tumor behaving as localized amyloidosis in a patient with long history of asymptomatic light chain myeloma. ( 23882901 )
2013
5
Amyloid tumor of the stomach simulating an obstructing gastric carcinoma: case report and review of the literature. ( 19288419 )
2009
6
Solitary amyloid tumor of the tongue base. ( 20107570 )
2009
7
Amyloid tumor of the breast mimicking breast carcinoma. ( 18364625 )
2008
8
Intracranial Aspergillus infection associated with an amyloid tumor and lymphoma. ( 19412411 )
2008
9
Aspiration cytology diagnosis of a primary amyloid tumor of thoracic vertebra: a case report. ( 15282731 )
2004
10
Amyloid tumor of the larynx associated with plasma cell infiltration: differential diagnosis. ( 15724743 )
2004
11
Amyloid tumor in the anterior mediastinum: report of a case. ( 15170548 )
2004
12
Fine needle aspiration cytology of a primary amyloid tumor of the breast. ( 15085770 )
2004
13
Amyloid tumor: a clinical and cytomorphologic study. ( 12768639 )
2003
14
Aspiration cytology diagnosis of a primary amyloid tumor of thoracic vertebra: a case report. ( 12951685 )
2003
15
Isolated amyloid tumor in the mediastinum: report of a case. ( 12658387 )
2003
16
AA-type amyloid tumor as an unsuspected cause of residual mass in a patient with large B-cell non-Hodgkin's lymphoma. ( 12002783 )
2002
17
Aspiration biopsy findings in amyloid tumor of the cervical vertebra. A case report. ( 11393073 )
2001
18
Localized amyloid tumor in small bowel. ( 11052330 )
2000
19
Localized amyloid tumor of the nasopharynx. ( 10652414 )
2000
20
Primary amyloid tumor (amyloidoma) of the jejunum with spheroid type of amyloid. ( 10212914 )
1999
21
Localized amyloid tumor of the tongue. A case report and review of the literature. ( 15678860 )
1998
22
Primary amyloidoma (amyloid tumor) of soft tissue. ( 9622729 )
1998
23
Intraabdominal immunoglobulin light chain amyloid tumor encompassing a vascular malformation. ( 9625589 )
1998
24
Primary localized amyloid tumor of the breast with osseous metaplasia. ( 9701018 )
1998
25
Primary amyloid tumor of the breast: a case report and review of the literature. ( 9237186 )
1997
26
Clinical and computed tomographic characteristics of amyloid tumor of the lacrimal gland. ( 8764792 )
1996
27
Ga-67 and Tc-99m (V) DMSA imaging in non-Hodgkin's lymphoma with amyloid tumor. ( 8565385 )
1995
28
Amyloid tumor of the sacrum. A case report. ( 7762341 )
1995
29
Recurrent amyloid tumor of the parotid gland. ( 7536425 )
1995
30
Localized primary amyloid tumor associated with osseous metaplasia presenting as bilateral breast masses: cytologic and radiologic features. ( 8287770 )
1993
31
Localized primary amyloid tumor of the thyroid developing in the course of Hashimoto's thyroiditis. ( 1570743 )
1992
32
[Craniocervical amyloid tumor with destructive spondyloarthropathy and myelocompression as a rare complication of long-term dialysis]. ( 2108522 )
1990
33
Subcutaneous amyloid-tumor of beta-2-microglobulin origin in a long-term hemodialysis patient. ( 2674745 )
1989
34
Case report 480: Periosteal amyloid tumor. ( 3375853 )
1988
35
Localized primary amyloid tumor of the parotid gland. ( 3186222 )
1988
36
Amyloid tumor of the spleen. ( 3307463 )
1987
37
Amyloid tumor (amyloidoma) of a peripheral nerve. ( 3021087 )
1986
38
Localized primary (AL) amyloid tumor of the breast. Cytologic, histologic, immunocytochemical and ultrastructural observations. ( 3526931 )
1986
39
Primary amyloid tumor of the breast. Case report and literature review. ( 3855589 )
1985
40
Amyloid tumor of the breast. ( 6831938 )
1983
41
Primary amyloid tumor of the lacrimal gland: CT findings. ( 6630639 )
1983
42
Case report 233. Amyloid tumor of the sternum as part of a solitary plasmacytoma. ( 6879219 )
1983
43
Amyloid tumor of the breast. ( 7166121 )
1982
44
Amyloid tumor of the orbit. ( 492520 )
1979
45
Amyloid tumor. A clinicopathologic study of four cases. ( 148847 )
1978
46
A case of amyloid tumor of the stomach. ( 631096 )
1978
47
Case report. Localized amyloid tumor of the bladder presenting as an anterior pelvic mass. ( 1155740 )
1975
48
Amyloid tumor of the breast. ( 4683157 )
1973
49
Amyloid tumor of the larynx. Case report with electron microscope study. ( 5030768 )
1972
50
Primary amyloid tumor of the trachea. A case report. ( 5022950 )
1972

Variations for Amyloid Tumor

Expression for Amyloid Tumor

Search GEO for disease gene expression data for Amyloid Tumor.

Pathways for Amyloid Tumor

Pathways related to Amyloid Tumor according to GeneCards Suite gene sharing:

id Super pathways Score Top Affiliating Genes
1 11.43 CALCA NF1 NF2 TUBB3
2 10.6 NF1 TTR

GO Terms for Amyloid Tumor

Biological processes related to Amyloid Tumor according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 regulation of cell proliferation GO:0042127 9.63 NF1 NF2 SPARC
2 cellular protein metabolic process GO:0044267 9.61 B2M CALCA TTR
3 extracellular matrix organization GO:0030198 9.54 NF1 SPARC TTR
4 pigmentation GO:0043473 9.48 NF1 SPARC
5 negative regulation of endothelial cell proliferation GO:0001937 9.4 NF1 SPARC
6 response to cadmium ion GO:0046686 9.32 B2M SPARC
7 negative regulation of osteoclast differentiation GO:0045671 9.26 CALCA NF1
8 negative regulation of MAPK cascade GO:0043409 9.16 NF1 NF2
9 negative regulation of cell-matrix adhesion GO:0001953 8.96 NF1 NF2
10 positive regulation of adenylate cyclase activity GO:0045762 8.62 CALCA NF1

Molecular functions related to Amyloid Tumor according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 hormone activity GO:0005179 8.8 CALCA TG TTR

Sources for Amyloid Tumor

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....